Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma

  1. Bergerot, C.
  2. Rha, S.Y.
  3. Pal, S.
  4. Koralewski, P.
  5. Stroyakovskiy, D.
  6. Alekseev, B.
  7. Parnis, F.
  8. Castellano, D.
  9. Lee, J.L.
  10. Sunela, K.
  11. Ciuleanu, T.
  12. Heng, D.
  13. Glen, H.
  14. Wang, J.
  15. Bennett, L.
  16. Pan, J.
  17. O'Hara, K.
  18. Puente, J.
Revista:
Oncologist

ISSN: 1549-490X,  1083-7159

Any de publicació: 2023

Volum: 28

Número: 1

Pàgines: 59-71

Tipus: Article

DOI: 10.1093/ONCOLO/OYAC142 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus